Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Curevac N.V. | CVAC | Sep 30, 2024 | 2.94 | -2.00 |
CuriosityStream | CURI | Sep 30, 2024 | 1.91 | -2.05 |
Curis | CRIS | Sep 30, 2024 | 5.39 | +0.19 |
CURRENC Group | CURR | Sep 30, 2024 | 2.50 | 0.00 |
Curtiss-Wright | CW | Sep 30, 2024 | 328.69 | +0.93 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Sep 30, 2024 | 45.01 | +0.92 |
Cushman & Wakefield | CWK | Sep 30, 2024 | 13.63 | -0.15 |
Custom Truck One Source | CTOS | Sep 30, 2024 | 3.45 | -4.17 |
Customers Bancorp | CUBI | Sep 30, 2024 | 46.45 | +2.36 |
Customers Bancorp E Pref | CUBI-E | Sep 30, 2024 | 25.40 | +0.01 |
Customers Bancorp F Pref | CUBI-F | Sep 30, 2024 | 25.22 | +0.44 |
Cutera | CUTR | Sep 30, 2024 | 0.79 | +2.70 |
CVB Financial | CVBF | Sep 30, 2024 | 17.82 | +0.51 |
CVD Equipment | CVV | Sep 30, 2024 | 3.31 | -0.30 |
CVR Energy | CVI | Sep 30, 2024 | 23.03 | -0.52 |
Cvr Partners LP Unit | UAN | Sep 30, 2024 | 67.13 | -0.40 |
CVRx | CVRX | Sep 30, 2024 | 8.81 | +2.09 |
CVS Health | CVS | Sep 30, 2024 | 62.88 | +2.44 |
CXApp A | CXAI | Sep 30, 2024 | 1.68 | -1.75 |
CyberArk Software | CYBR | Sep 30, 2024 | 291.61 | +3.08 |
Cybin | CYBN | Sep 30, 2024 | 8.89 | -7.40 |
Cyclacel Pharmaceuticals | CYCC | Sep 30, 2024 | 0.99 | -3.88 |
Cyclacel Pharmaceuticals Pref | CYCCP | Sep 30, 2024 | 7.00 | 0.00 |
Cyclerion Therapeutics | CYCN | Sep 30, 2024 | 2.59 | -0.97 |
Cyclo Therapeutics | CYTH | Sep 30, 2024 | 0.79 | +9.58 |
Cyngn | CYN | Sep 30, 2024 | 3.89 | +1.04 |
Cytek Biosciences | CTKB | Sep 30, 2024 | 5.54 | +2.78 |
Cytokinetics | CYTK | Sep 30, 2024 | 52.80 | +0.88 |
Cytomed Therapeutics | GDTC | Sep 30, 2024 | 1.57 | +1.29 |
CytomX Therapeutics | CTMX | Sep 30, 2024 | 1.18 | -1.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.